Abstract:The natural history of COPD is complex, and the disease is best understood as a syndrome resulting from numerous interacting factors throughout the life cycle with smoking being the strongest inciting feature. Unfortunately, diagnosis is often delayed with several longitudinal cohort studies shedding light on the long 'preclinical' period of COPD. It is now accepted that individuals presenting with different COPD phenotypes may experience varying natural history of their disease. This includes its inception, early stages and progression to established disease. Several scenarios regarding lung function course are possible, but it may conceptually be helpful to distinguish between individuals with normal maximally attained lung function in their early adulthood who thereafter experience faster than normal FEV1 decline, and those who may achieve a lower than normal maximally attained lung function. This may be the main mechanism behind COPD in the latter group, as the decline in FEV1 during their adult life may be normal or only slightly faster than normal. Regardless of the FEV1 trajectory, continuous smoking is strongly associated with disease progression, development of structural lung disease and poor prognosis. In developing countries, factors such as exposure to biomass and sequelae after tuberculosis may lead to a more airway‐centred COPD phenotype than seen in smokers. Mechanistically, COPD is characterized by a combination of structural and inflammatory changes. It is unlikely that all patients share the same individual or combined mechanisms given the heterogeneity of resultant phenotypes. Lung explants, bronchial biopsies and other tissue studies have revealed important features. At the small airway level, progression of COPD is clinically imperceptible, and the pathological course of the disease is poorly described. Asthmatic features can further add confusion. However, the small airway epithelium is likely to represent a key focus of the disease, combining impaired subepithelial crosstalk and structural/inflammatory changes. Insufficient resolution of inflammatory processes may facilitate these changes. Pathologically, epithelial metaplasia, inversion of the goblet to ciliated cell ratio, enlargement of the submucosal glands and neutrophil and CD8‐T‐cell infiltration can be detected. Evidence of type 2 inflammation is gaining interest in the light of new therapeutic agents. Alarmin biology is a promising area that may permit control of inflammation and partial reversal of structural changes in COPD. Here, we review the latest work describing the development and progression of COPD with a focus on lung function trajectories, exacerbations and survival. We also review mechanisms focusing on epithelial changes associated with COPD and lack of resolution characterizing the underlying inflammatory processes.

Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions

Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer

COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series)

Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease

Inflammation and Immune Response in COPD: Where Do We Stand?

Epithelial and endothelial cell plasticity in chronic obstructive pulmonary disease (COPD)

The persistent inflammation in COPD: is autoimmunity the core mechanism?

How Do Innate Immune Cells Contribute to Airway Remodeling in COPD Progression?

Aspects on pathophysiological mechanisms in COPD

Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development.

Lipid Metabolism In Chronic Obstructive Pulmonary Disease

Targeting Lung Inflammation: Novel Therapies for the Treatment of COPD.

Pathological changes in the COPD lung mesenchyme--novel lessons learned from in vitro and in vivo studies.

Natural history and mechanisms of COPD

Role of Airway Epithelial Cells in Development of Chronic Obstructive Pulmonary Disease

Pathophysiology of the Small Airways in Chronic Obstructive Pulmonary Disease

Immune Dysregulation in Chronic Obstructive Pulmonary Disease

Clinical utilization of airway inflammatory biomarkers in the prediction and monitoring of clinical outcomes in patients with chronic obstructive pulmonary disease

The role of airway remodeling in the pathogenesis and treatment of chronic obstructive pulmonary disease

The Importance of the Interleukin-8 Study in Chronic Obstructive Pulmonary Disease

Inflammatory and Immune Mechanisms in COPD: Current Status and Therapeutic Prospects